Robaxin vs. Soma

See how Robaxin and Soma compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Robaxin (methocarbamol) is not a controlled substance, while Soma (carisoprodol) is a Schedule IV drug with abuse and dependence risk.

  • Both drugs treat short-term discomfort from acute musculoskeletal injuries, and neither is approved for long-term or chronic pain.

  • Robaxin comes in oral and injectable forms, while Soma is only available as an oral tablet and is limited to 2 to 3 weeks of use.

Robaxin vs. Soma Drug Summary

Robaxin

Robaxin (methocarbamol) is a centrally-acting skeletal muscle relaxant used alongside rest and physical therapy for acute musculoskeletal pain. It comes as an oral tablet or an IV/IM injection, with the injectable form also used as adjunct therapy for tetanus. Robaxin has been available since 1957 and is not a federally controlled substance.

Soma

Soma (carisoprodol) is a skeletal muscle relaxant used short-term for discomfort from acute musculoskeletal conditions in adults. It is taken as an oral tablet three times daily plus a bedtime dose, for no more than 2 to 3 weeks. Soma is a Schedule IV controlled substance due to its potential for misuse and dependence.

Robaxin vs. Soma Side Effects

Robaxin

Most common
Drowsiness (rate not specified)
Headache (rate not specified)
Nausea (rate not specified)
Blurred vision (rate not specified)

Soma

Most common
Drowsiness (up to 17%)
Headache (>2%)
Dizziness (>2%)
Tachycardia (post-marketing)

Robaxin vs. Soma Dosage

Robaxin

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 1500 mg four times daily Days 1-3
Maximum dose 1000 mg IM/IV per dose If needed
Dose changes 2 increases Every 3 days

Soma

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 250 mg to 350 mg TID + HS At the start
Maximum dose 250 mg to 350 mg TID + HS Same as starting
Dose changes None Fixed dose

Robaxin vs. Soma Indications

Robaxin

Robaxin is FDA-approved as an adjunct to rest and physical therapy for relief of discomfort from acute, painful musculoskeletal conditions. The injectable form is also used as adjunctive therapy in tetanus management. It is not approved for chronic pain or for children under 16.

  • Adjunct to rest and physical therapy for acute muscle pain

  • Adjunctive therapy in tetanus (injectable form only)

  • Not approved for chronic or long-term pain management

  • Not approved for patients under 16 years old

Soma

Soma is FDA-approved for short-term relief of discomfort from acute, painful musculoskeletal conditions in adults. It is intended for use of no more than 2 to 3 weeks, since longer-term efficacy hasn't been established. Soma is not approved for children or for chronic musculoskeletal pain.

  • Short-term relief of acute musculoskeletal pain in adults

  • Limited to 2 to 3 weeks of use

  • Not approved for chronic pain conditions

  • Not approved for pediatric patients

Robaxin vs. Soma Pros and Cons

Robaxin

Robaxin offers a non-controlled option for short-term muscle pain relief, with both oral and injectable forms available for different care settings. Its exact side effect rates aren't detailed in the label, but reported reactions are typical for this drug class. It has a long track record of use dating back to 1957.

Pros

  • Not a controlled substance, so lower abuse/dependence risk

  • Available as both oral tablets and IV/IM injection

  • Can be used for tetanus adjunct therapy in hospital settings

Cons

  • Exact side effect rates aren't specified in FDA labeling

  • Requires frequent dosing, up to four times daily, during titration

  • Injectable form can cause tissue injury if given improperly

  • Not studied or approved for chronic pain use

Soma

Soma provides effective short-term muscle relaxation but carries a Schedule IV controlled substance designation because of its misuse potential. Its use is restricted to 2 to 3 weeks since longer-term benefit and safety haven't been established. Its active metabolite, meprobamate, adds to its sedative and dependence-related risks.

Pros

  • Simple fixed dosing schedule, three times daily plus bedtime

  • Well-documented short-term efficacy for acute muscle pain

  • Oral-only tablet, no injectable administration needed

Cons

  • Schedule IV controlled substance with misuse and diversion risk

  • Risk of withdrawal symptoms if stopped abruptly after prolonged use

  • Limited to 2 to 3 weeks, unsuitable for ongoing pain

  • Active metabolite meprobamate is itself a controlled sedative

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.